|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Mar―02 |
2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities |
Raman Singh, Vidushi Gupta, Antresh Kumar, Kuldeep Singh, Srinivas Mutalik |
2 |
[GO] |
2023―Feb―01 |
Adverse Drug Reactions during COVID-19 Treatment: A Comprehensive Analysis Focused on Hospitalized Patients, with the Use of a Survey in Cuba in 2020 |
Lizette Gil-del-Valle, Rosario Gravier-Hernández, Waldemar Baldoquin-Rodríguez, Beatriz Sierra-Vázquez, Ana Beatriz Perez-Díaz, Pablo Sariol-Resik, et al. (+12) Tatiana Prieto-Dominguez, Mario Manuel Delgado-Guerra, Joniel Arnoldo Sánchez- Márquez, Olga Elena López-Fernández, Faustina Fonseca-Betancourt, Liana Valdés-Lanza, Odalys Orraca-Castillo, Xaveer Van Ostade, Wim Vanden Berghe, Veerle Vanlerberghe, M. Guadalupe Guzmán-Tirado, Koteshwara Mudigonda |
3 |
[GO] |
2022―Dec―27 |
Psychological Distress among Pharmacists during Second Wave of Pandemic: A Cross-Sectional Study |
Keshav Dhakal, Shobhana Nepal, Pratigya Sapkota, Rizky Abdulah |
4 |
[GO] |
2022―Nov―09 |
Molecular Docking and Dynamics Simulation of Several Flavonoids Predict Cyanidin as an Effective Drug Candidate against SARS-CoV-2 Spike Protein |
Asmita Shrestha, Rishab Marahatha, Saroj Basnet, Bishnu P. Regmi, Saurav Katuwal, Salik Ram Dahal, et al. (+5) Khaga Raj Sharma, Achyut Adhikari, Ram Chandra Basnyat, Niranjan Parajuli, Mounir Tilaoui |
5 |
[GO] |
2022―Aug―10 |
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19 |
Heidi N du Preez, Colleen Aldous, Hendrik G Kruger, Lin Johnson, Benedetto Natalini |
6 |
[GO] |
2022―Jul―21 |
Evaluation and Clinical Validation of Guanidine-Based Inactivation Transport Medium for Preservation of SARS-CoV-2 |
Hesti L. Wiraswati, Shabarni Gaffar, Savira Ekawardhani, Nisa Fauziah, Fedri R. Rinawan, Leonardus Widyatmoko, et al. (+6) Amila Laelalugina, Annissa R. Arimdayu, Tri Kusniati, Clarisa D. Andari, Lia Faridah, Benedetto Natalini |
7 |
[GO] |
2021―Nov―02 |
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics |
Lennox Chitsike, John Krstenansky, Penelope J. Duerksen-Hughes, Abdeslam Jaafari |
8 |
[GO] |
2020―Sep―21 |
Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds |
Vinod P. Raphael, Shaju K. Shanmughan |